Cevitera HCT Tablet 10/40/12.5 mg

Adult dose

This medication should be taken once daily, 1 tablet with water, regardless of meals. It is recommended to take it at the same time each day (e.g., morning) if possible. The recommended dosages are as follows: - 5/20/12.5mg: Given to patients whose blood pressure is not adequately controlled with Amlodipine/Olmesartan Medoxomil 5/20mg combination therapy. - 5/40/12.5mg: Given to patients whose blood pressure is not adequately controlled with Amlodipine/Olmesartan Medoxomil 5/40mg.

Child dose

The safety and efficacy in pediatric patients under 18 years have not been established, so the use of this drug is not recommended.

This medication may cause serious harm to the fetus and newborn in the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. This drug is contraindicated in patients with allergies to this medication or its ingredients, or with specific heart, kidney, or liver diseases. Patients with excessively low blood pressure or in acute heart failure should not take this medication. Patients with reduced blood volume may experience hypotension when starting this drug, so careful monitoring is necessary. Patients with impaired kidney function should have regular checks of kidney function and electrolyte levels while taking this drug. Patients with poor liver function should also be specially cautious when using this medication. This drug may cause dizziness or lightheadedness because of its blood pressure-lowering effects; therefore, patients should avoid driving or operating hazardous machinery. In addition, this medication may interact with various other drugs, so if the patient is taking other medications, they must inform their physician or pharmacist. Overdose of this medication may result in severe hypotension or arrhythmias; if any unusual symptoms occur, the patient should visit a medical facility immediately. This medication is not recommended for children or adolescents under 18 years of age as its safety and efficacy have not been established. In the elderly, the sensitivity to the drug may increase due to decreased kidney and liver function, so starting with a lower dose and careful monitoring is necessary. Use of this medication during breastfeeding is not recommended, as continuing to breastfeed may cause adverse reactions in the infant. While taking this drug, patients should avoid excessive sun exposure and consult a physician immediately if any skin abnormalities occur.

Serious side effects

Hives, severe swelling (edema), anaphylaxis, severe rash with high fever, blistering, skin peeling, pain in mucous membranes of the mouth/eyes, severe skin reactions, difficulty breathing or shortness of breath, asthma attacks, respiratory abnormalities accompanied by cough and fever, dyspnea, respiratory distress syndrome, pulmonary edema, yellowing of the skin or eyes (jaundice), jaundice (cholestatic jaundice), sudden and very severe headache, syncope, seizures.

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory tract infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly sealed container. The storage temperature should be kept at room temperature between 1 and 30 degrees Celsius. This helps maintain the efficacy of the drug.

Appearance

Grayish-red round film-coated tablet

Package unit

28 tablets (14 tablets/PTP x 2) / carton